Iriscope for diagnosing lung lesions
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a new device, called Iriscope, which may help doctors see and diagnose lung lesions better during a bronchoscopy. If you have a lung spot seen on a CT scan and are scheduled for a bronchoscopy, this study could help improve your diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have a lung lesion between 20 and 50 mm (about the size of a grape to a lime) seen on a recent CT scan.
- Your doctor plans to do a bronchoscopy to check the lesion.
- You agree to take part and can sign the consent form in French or with an interpreter.
- You are not pregnant or breastfeeding, and you do not have bleeding problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a robotic bronchoscopy system to biopsy small lung nodules that are hard to reach with standard tools. It aims to help diagnose nodules that don't show a clear airway path on CT scans.
This trial tests if a special microscope (confocal laser endomicroscopy) used during a bronchoscopy can help doctors see and diagnose suspicious lung spots more clearly. It may help you if you have a small-to-medium sized spot in your lung that needs a biopsy.
This study tests a new microscope probe called CelTouch that doctors can use during a lung biopsy to see cells in real time, which may help diagnose lung lesions more accurately.
This study tests a new microscope-like tool that helps doctors see lung spots more clearly during a biopsy. It may help get a more accurate diagnosis with fewer procedures.
This study tests a special microscope attached to a bronchoscopy scope that helps doctors see lung tissue in real time. It may help identify whether a lung nodule is cancer more quickly and accurately during the same procedure.
This trial tests a special imaging technique that uses a harmless dye to help surgeons see the exact boundary between healthy and diseased lung tissue during surgery to remove a small part of the lung. This could help make the surgery more precise and potentially preserve more healthy lung.
Hear when a new Lung Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.